Your browser doesn't support javascript.
loading
Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study.
Sicklick, Jason K; Kato, Shumei; Okamura, Ryosuke; Patel, Hitendra; Nikanjam, Mina; Fanta, Paul T; Hahn, Michael E; De, Pradip; Williams, Casey; Guido, Jessica; Solomon, Benjamin M; McKay, Rana R; Krie, Amy; Boles, Sarah G; Ross, Jeffrey S; Lee, J Jack; Leyland-Jones, Brian; Lippman, Scott M; Kurzrock, Razelle.
Afiliação
  • Sicklick JK; Department of Surgery, Division of Surgical Oncology, UC San Diego School of Medicine, San Diego, CA, USA. jsicklick@health.ucsd.edu.
  • Kato S; Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, USA. jsicklick@health.ucsd.edu.
  • Okamura R; Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, USA.
  • Patel H; Department of Medicine, Division of Hematology Oncology, UC San Diego School of Medicine, San Diego, CA, USA.
  • Nikanjam M; Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, USA.
  • Fanta PT; Department of Medicine, Division of Hematology Oncology, UC San Diego School of Medicine, San Diego, CA, USA.
  • Hahn ME; Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, USA.
  • De P; Department of Medicine, Division of Hematology Oncology, UC San Diego School of Medicine, San Diego, CA, USA.
  • Williams C; Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, USA.
  • Guido J; Department of Medicine, Division of Hematology Oncology, UC San Diego School of Medicine, San Diego, CA, USA.
  • Solomon BM; Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, USA.
  • McKay RR; Department of Medicine, Division of Hematology Oncology, UC San Diego School of Medicine, San Diego, CA, USA.
  • Krie A; Department of Radiology, UC San Diego School of Medicine, San Diego, CA, USA.
  • Boles SG; Avera Cancer Institute, Sioux Falls, SD, USA.
  • Ross JS; Avera Cancer Institute, Sioux Falls, SD, USA.
  • Lee JJ; Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, USA.
  • Leyland-Jones B; Avera Cancer Institute, Sioux Falls, SD, USA.
  • Lippman SM; Center for Personalized Cancer Therapy, Moores Cancer Center, UC San Diego Health, 3855 Health Sciences Drive, Mail Code 0658, La Jolla, CA, 92093-0658, USA.
  • Kurzrock R; Department of Medicine, Division of Hematology Oncology, UC San Diego School of Medicine, San Diego, CA, USA.
Genome Med ; 13(1): 155, 2021 10 04.
Article em En | MEDLINE | ID: mdl-34607609
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Genome Med Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Genome Med Ano de publicação: 2021 Tipo de documento: Article